$NOK I think $6 by end of year is a really strong conservative price target. Based on their Q1 earnings, it seems like the company should be able to post about .30 in earnings on the year which would give them a 20 P/E at $6. Q1 is usually the weakest quarter, and although Pekka said he expected to see less of a seasonality effect on earnings this year, I think they should see sharp net sales increases in Q3 and Q4 from Europe as the continent ups vaccinations and slowly reopens. 30 cents in earnings on the year (not including any once off payments for patents lawsuits, etc) would show that Pekka's strategies are working, and would all but guarantee a dividend for the year.